Dyspnea, respiratory function and sputum profile in asthmatic patients during exacerbations

Respiratory Medicine

Volumn 96, Issue 9, 2002, Pages 745-750

  Rosi, E ^a   Lanini, B ^b   Ronchi, M C ^a   Romagnoli, I ^b   Stendardi, L ^b   Bianchi, R ^b   Zonefrati, R ^a   Duranti, R ^a   Scano, G ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Asthma; Dyspnea; Eosinophils; Inspiratory capacity; Peak expiratory flow

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN;

ADULT; AGED; AIRWAY; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG RESPONSE; DYSPNEA; FORCED EXPIRATORY VOLUME; HUMAN; HYPOTHESIS; INFLAMMATION; INSPIRATORY CAPACITY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SPUTUM ANALYSIS; STATISTICAL ANALYSIS; VISUAL ANALOG SCALE;

EID: 0036738957     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2002.1343     Document Type: Article

References (35)

1. NHLBI. International consensus report on diagnosis and management of asthma. Eur Respir J 1992; 5: 601-641.
2. Turcotte H, Corbeil F, Boulet LP. Perception of breathlessness during bronchoconstriction induced by antigen, exercise and histamine challenges. Thorax 1990; 45: 917-918.
3. Boulet LP, Deschesnes F, Turcotte H, Gignac F. Near-fatal asthma: clinical and physiologic features, perception of bronchoconstriction, and psychologic profile. J Allergy Clin Immunol 1991; 88: 838-846.
4. Roisman GL, Peiffer C, Lacronique JG, Le Cae A, Dusser DJ. Perception of bronchial obstruction in asthmatic patients. J Clin Invest 1995; 96: 12-21.
5. in't Veen JC, Smits HH, Ravensberg AJ, Hiemstra PS, Sterk PJ, Bel EH. Impaired perception of dyspnoea in patients with severe asthma. Am J Respir Crit Care Med 1998; 158: 1134-1141.
6. Ottanelli R, Rosi E, Romagnoli I, et al. Do inhaled corticosteroids affect perception of dyspnea during bronchoconstriction in asthma? Chest 2001; 120: 770-777.
7. Rodrigo G, Rodrigo C. Assessment of the patient with acute asthma in the emergency department. A factor analytic study. Chest 1993; 104: 1325-1328.
8. Janson C, Herala M. Dyspnea in acute asthma: relationship with other clinical and physiologic variables. Ann Allergy 1993; 70: 400-404.
9. Noseda A, De Bruyne MD, De Maertelaer V, Yernault JC. Does an IV bolus of methylprednisolone relieve dyspnea in asthma exacerbation? Chest 2000; 118: 1530-1537.
10. Lougheed MD, Lam M, Forkert L, Webb KA, O'Donnell DE. Breathlessness during acute bronchoconstriction in asthma: pathophysiologic mechanisms. Am Rev Respir Dis 1993; 148: 1452-1459.
11. Killian KJ, Watson R, Otis J, St Amand TA, O'Byrne PM. Symptom perception during acute bronchoconstriction. Am J Respir Crit Care Med 2000; 162: 490-496.
12. Scano G, Garcia Herreros P, Stendardi L, Degre S, De Coster A, Sergysels R. Cardiopulmonary adaptation to exercise in coal miners. Arch Environ Health 1980; 35: 360-366.
13. European Community for Coal and Steel. Standardization of lung function tests. Eur Respir J 1993; 6(Suppl 16): 1-100.
14. Boezen HM, Shouten JP, Postma DS, Rijcken B. Distribution of peak expiratory flow variability by age, gender and smoking habits in a random population sample aged 20-70 yrs. Eur Respir J 1994; 7: 1814-1820.
15. Peiffer C, Marsac J, Lockhart A. Chronobiological study of the relationship between dyspnoea and airway obstruction in symptomatic asthmatic subjects. Clin Sci 1989; 77: 237-244.
16. Pin I, Gibson PG, Kolendowicz R, et al. Use of sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29.
17. Ronchi MC, Piragino C, Rosi E, Amendola M, Duranti R, Scano G. Role of sputum differential count in detecting airway inflammation in patients with chronic bronchial asthma. Thorax 1996; 51: 1-5.
18. Reddel HK, Salome CM, Peat JK, Woolcock AJ. Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med 1995; 151: 1320-1325.
19. Higgins B. Peak expiratory flow variability in the general population. Eur Respir J 1997; 10: 45s-48s.
20. Wilson RC, Jones PW. A comparison of the visual analogue scale and modified BORG scale for the measurement of dyspnea during exercise. Clin Sci 1989; 76: 277-282.
21. Noseda A, Schmerber J, Prigogine T, Yernault JC. Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: variability and sensitivity of a visual analogue scale in patients with asthma or COPD. Eur Respir J 1992; 5: 1043-1053.
22. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-457.
23. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
24. Ronchi MC, Piragino C, Rosi E, et al. Do sputum eosinophils and ECP relate to the severity of asthma? Eur Respir J 1997; 10: 1809-1813.
25. Pizzichini MMM, Pizzichini E, Clelland L, et al. Sputum in severe exacerbation of asthma. Kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997; 155: 1501-1508.
26. Fahy JV, Boushey HA. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. Eur Respir J 1998; II: 1240-1247.
27. Martin JG, Shore S, Engel LA. Mechanical load and inspiratory muscle action during induced asthma. Am Rev Respir Dis 1983; 128: 455-460.
28. Gorini M, Misuri G, Duranti R, Iandelli I, Mancini M, Scano G. Abdominal muscle recruitment and PEEPi during bronchoconstriction in chronic obstructive pulmonary disease. Thorax 1997; 52: 355-361.
29. Rochester DF. Tests of respiratory muscle function. Clin Chest Med 1988; 9: 249-261.
30. Gorini M, Spinelli A, Gigliotti F, Duranti R, Arcangeli P, Scano G. Changes in neural drive (EMGd) and neuromuscular coupling during histamine-induced bronchoconstriction in patients with asthma. Eur Respir J 1988; 1: 691-697.
31. Manning HL, Schwartzestein RM, Pathophysiology of dyspnea. N Engl J Med 1995; 333: 1547-1553.
32. Kirby JG, Juniper EF, Hargreave FE, Zamel N. Total lung capacity does not change during methacholine-stimulated airway narrowing. J Appl Physiol 1986; 61: 2144-2147.
33. Hetzel MR, Clark TJH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35: 732-738.
34. Britton J. Measurement of peak expiratory flow variability in community populations: methodology. Eur Respir J 1997; 10: 42s-44s.
35. Quanjer PH, Lebowitz MD, Gregg I, Miller MR, Pedersen OF. Peak expiratory flow: conclusions and recommendations of a Working Party of the European Respiratory Society. Eur Respir J 1997; 10: 2s-8s.